ebook Munafa Stock Market Course + Intraday & FNO calls  

       

CRSP announcements Crispr Therapeutics Ag announcements and dividends declared NASDAQ

Crispr Therapeutics Ag Complete list of announcements declared & dividend announcements by Crispr Therapeutics Ag CRSP

Crispr Therapeutics Ag CRSP listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Crispr Therapeutics Ag CRSP

CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings on Feb. 13. At first glance, that may seem contradictory. The company posted a larger net loss than forecast, and revenue came in a
Announcement as on 19 February 2026

Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026?
Key PointsCRISPR has incurred nearly 0 million in losses over the past four quarters.
Announcement as on 19 December 2025

CRISPR Therapeutics AG (CRSP) Stock Drops Despite Market Gains: Important Facts to Note
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at .16, representing a -2.56% change from its previous close.
Announcement as on 07 November 2025

CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Announcement as on 09 October 2025

CRISPR Therapeutics Reports Promising Phase 1 Clinical Data for CTX310â„¢ and Updates on Cardiovascular Disease Programs
CRISPR Therapeutics reports promising Phase 1 clinical data for CTX310™, with significant triglyceride and LDL reductions, and updates on other programs.
Announcement as on 26 June 2025

Announcements by Crispr Therapeutics Ag first page | Next page |

CRSP Crispr Therapeutics Ag current price & indicator signals

Moving Averages for Crispr Therapeutics Ag

  • 5Day Average: 58.54
  • 12Day Average: 57.39
  • 20Day Average: 54.86
  • 50Day Average: 54.35
  • 100Day Average: 56.39
  • 150Day Average: 57.37
  • 200Day Average: 55.31

CRSP Indicators & signals

Indicator MACD (12,26,9)

57.09, 55.58, 1.19
Indicator MACD is in positive zone

Indicator ADX (14)

6.06, 20.65, 18.29
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of CRSP Crispr Therapeutics Ag are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Fri Mar 2026 56.53 54.80 to 57.64 -1.4% 0.41 times
05 Thu Mar 2026 57.33 56.55 to 59.82 -4.45% 1.02 times
04 Wed Mar 2026 60.00 57.75 to 60.60 3.34% 0.78 times
03 Tue Mar 2026 58.06 56.41 to 59.37 -4.46% 0.97 times
02 Mon Mar 2026 60.77 57.25 to 61.00 1.05% 0.88 times
27 Fri Feb 2026 60.14 58.50 to 61.49 -2.59% 1.12 times
26 Thu Feb 2026 61.74 53.75 to 61.76 11.85% 1.6 times
25 Wed Feb 2026 55.20 55.14 to 58.50 -2.77% 0.81 times
24 Tue Feb 2026 56.77 54.01 to 57.30 5.17% 1.12 times
23 Mon Feb 2026 53.98 52.02 to 54.83 0.97% 0.85 times
20 Fri Feb 2026 53.46 52.92 to 55.05 -2.16% 0.86 times
19 Thu Feb 2026 54.64 52.00 to 54.70 2.09% 0.65 times

Videos related to: CRSP announcements Crispr Therapeutics Ag announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

CRSP announcements Crispr Therapeutics Ag announcements and dividends declared NASDAQ

 

Back to top